Drug Trial Radar · NCT01651000
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
Last checked: Nov 19, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
213
Actual
Start
Sep 2012
Primary completion
Jul 2014
Study completion Jul 2014
Sponsor
- Lead sponsor
- OPKO IP Holdings II, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy of CTAP101 Capsules versus placebo in reducing intact parathyroid hormone (iPTH) by at least 30% from pretreatment baseline; safety and tolerability of CTAP101 will also be evaluated
Conditions
- Chronic Kidney Disease
- Hyperparathyroidism, Secondary
- Vitamin D Deficiency
Interventions
CTAP101 30 μg capsulesDrug
CTAP101 30 μg capsule taken daily at bedtime.
Sugar pill to CTAP101 30 μg capsulesOther
Sugar pill capsule (placebo to CTAP101 30 μg capsule) taken daily at bedtime.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants in the Intent to Treat Population With Decrease in Plasma Intact Parathyroid Hormone (iPTH) of ≥30% From Pre-treatment Baseline ValuesTime frame: Approximately 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
OPKO Renal
Bannockburn, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.